LPCAT1 and MRPL9 Promote Hepatocellular Carcinoma Progression via AKT Phosphorylation and Define a Mitochondrial Prognostic Model.

Hui Yang, Ziqi Zhu, Hanwen Zhu, Nanjing Li, Sinian Zheng, Ling Hu, Zhenru Wu, Yujun Shi

Abstract read

In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

A mitochondrial function-based prognostic model for hepatocellular carcinoma uncovers MRPS15 as a key driver of tumor progression through oxidative phosphorylation.Translational cancer research · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui YangDepartment of Pathology & Institute of Clinical Pathology, Institute of Transplantation, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu 610041, China.

Ziqi ZhuDepartment of Pathology & Institute of Clinical Pathology, Institute of Transplantation, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu 610041, China.

Hanwen ZhuWest China School of Medicine, Sichuan University, Chengdu 610041, China.

Nanjing LiDivision of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.

Sinian ZhengDepartment of Pathology & Institute of Clinical Pathology, Institute of Transplantation, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu 610041, China.

Ling HuDepartment of Pathology & Institute of Clinical Pathology, Institute of Transplantation, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu 610041, China.

Zhenru WuDepartment of Pathology & Institute of Clinical Pathology, Institute of Transplantation, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu 610041, China.

Yujun ShiDepartment of Pathology & Institute of Clinical Pathology, Institute of Transplantation, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu 610041, China.

Funding

China Postdoctoral Science Foundation 2023M742465National Natural Science Foundation of China 82072689National Natural Science Foundation of China 82300710Science Foundation of Sichuan 2025ZNSFSC1884Sichuan Province Science and Technology Department Project 2024YFFK0312

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hepatocellular carcinomaimmunotherapymitochondrial-related genesprognosis

Identifiers

PMID41976367

DOI10.3390/cancers18071144

PMCPMC13072332

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.